已收盤 03-27 16:00:00 美东时间
-1.500
-5.14%
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - March 30 ...
03-28 03:00
今日重点评级关注:HC Wainwright & Co.:维持OCUGEN"买入"评级,目标价从7美元升至10美元;HC Wainwright & Co.:维持Maze Therapeutics"买入"评级,目标价从60美元升至110美元
03-26 11:41
DA Davidson analyst Lucky Schreiner maintains Progress Software (NASDAQ:PRGS) with a Buy and lowers the price target from $70 to $50.
03-25 23:32
Progress Software's ShareFile now offers Advanced Electronic Signatures (AES) and Qualified Electronic Signatures (QES) with eIDAS compliance, simplifying UK and EU regulatory adherence and reducing reliance on multiple signing tools. These features integrate seamlessly into a secure, AI-powered workflow, supporting document collaboration, approval, and storage in one unified platform, enhancing operational efficiency and compliance.
03-25 13:00
Progress Software schedules quarterly earnings release and conference call Progress will release fiscal first-quarter 2026 financial results after the market close on March 30, 2026. It will host a conference call at 5:00 p.m. ET on March 30, 2026, with a live webcast available at . Disclaimer: This
03-16 21:02
Progress Software (PRGS) pared a decline, edging lower by 1%, amid some takeover speculation. There's speculation that Progress Software (PRGS) is a takeover target and that private equity firm Thoma...
03-14 02:59
Progress Software has opened applications for its 2026 Global STEM Scholarship Series, supporting students in the U.S., Bulgaria, and India pursuing STEM degrees. The program includes three scholarships: the Mary Székely Scholarship (U.S.), Women in STEM Scholarship (Bulgaria), and Akanksha Scholarship for Women in STEM (India). Applications are due by April 13, 2026.
03-10 13:00
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
DA Davidson analyst Lucky Schreiner maintains Progress Software (NASDAQ:PRGS) with a Buy and maintains $70 price target.
02-05 03:33
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46